BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37066817)

  • 1. Microvascular Dysfunction Is Associated With Impaired Myocardial Work in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Multimodality Study.
    Garcia Brás P; Rosa SA; Cardoso I; Branco LM; Galrinho A; Gonçalves AV; Thomas B; Viegas JM; Fiarresga A; Branco G; Pereira R; Selas M; Silva F; Cruz I; Baquero L; Ferreira RC; Lopes LR
    J Am Heart Assoc; 2023 Apr; 12(8):e028857. PubMed ID: 37066817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis.
    Galli E; Vitel E; Schnell F; Le Rolle V; Hubert A; Lederlin M; Donal E
    Echocardiography; 2019 Jan; 36(1):74-82. PubMed ID: 30488501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial work is associated with significant left ventricular myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Gonçalves AV; Rosa SA; Branco L; Galrinho A; Fiarresga A; Lopes LR; Thomas B; Baquero L; Carmo MM; Ferreira RC
    Int J Cardiovasc Imaging; 2021 Jul; 37(7):2237-2244. PubMed ID: 33598850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Left Ventricular Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy by Speckle Tracking Automated Functional Imaging.
    Hu X; Bao Y; Zhu Y; Zheng K; Zhang J; Zhou W; Deng Y; Liu Y
    Ultrasound Med Biol; 2023 May; 49(5):1309-1317. PubMed ID: 36863952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.
    Wabich E; Dorniak K; Zienciuk-Krajka A; Nowak R; Raczak G; Daniłowicz-Szymanowicz L
    J Cardiol; 2021 May; 77(5):475-481. PubMed ID: 33246844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias.
    Song Y; Bi X; Chen L; Yang K; Chen X; Dong Z; Wang J; Kong X; Zhao K; Wang H; Duru F; Lu M; Ma L; Qiao S; Zhao S
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1006-1015. PubMed ID: 35167663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
    Almaas VM; Haugaa KH; Strøm EH; Scott H; Smith HJ; Dahl CP; Geiran OR; Endresen K; Aakhus S; Amlie JP; Edvardsen T
    Heart; 2014 Apr; 100(8):631-8. PubMed ID: 24368281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry.
    Heydari B; Satriano A; Jerosch-Herold M; Kolm P; Kim DY; Cheng K; Choi YL; Antiochos P; White JA; Mahmod M; Chan K; Raman B; Desai MY; Ho CY; Dolman SF; Desvigne-Nickens P; Maron MS; Friedrich MG; Schulz-Menger J; Piechnik SK; Appelbaum E; Weintraub WS; Neubauer S; Kramer CM; Kwong RY;
    JACC Cardiovasc Imaging; 2023 Apr; 16(4):478-491. PubMed ID: 36648040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.
    Gyllenhammar T; Fernlund E; Jablonowski R; Jögi J; Engblom H; Liuba P; Arheden H; Carlsson M
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1350-7. PubMed ID: 25139907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional prognostic values of strain and strain rate over late gadolinium enhancement in hypertrophic cardiomyopathy patients.
    Qin L; Zhu S; Liu P; Zhu L; Chen C; Gu S; Yang W; Zhou M; Yan F
    Int J Cardiol; 2023 Jan; 370():427-434. PubMed ID: 36332750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rest and Stress Longitudinal Systolic Left Ventricular Mechanics in Hypertrophic Cardiomyopathy: Implications for Prognostication.
    Pozios I; Pinheiro A; Corona-Villalobos C; Sorensen LL; Dardari Z; Liu HY; Cresswell K; Phillip S; Bluemke DA; Zimmerman SL; Abraham MR; Abraham TP
    J Am Soc Echocardiogr; 2018 May; 31(5):578-586. PubMed ID: 29426649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Work in Nonobstructive Hypertrophic Cardiomyopathy: Implications for Outcome.
    Hiemstra YL; van der Bijl P; El Mahdiui M; Bax JJ; Delgado V; Marsan NA
    J Am Soc Echocardiogr; 2020 Oct; 33(10):1201-1208. PubMed ID: 32680744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
    Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.